
Correction: Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
Author(s) -
Tong Shen,
Yehong Kuang,
Charles R. Ashby,
Lei Yu,
Angel Chen,
Ying Zhao,
Xiang Chen,
Amit K. Tiwari,
Elizabeth Hopper-Borge,
Jian Ouyang,
ZheSheng Chen
Publication year - 2009
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/annotation/e57b4610-9029-48db-9d57-5cc0fa35b8ac
Subject(s) - nilotinib , imatinib , efflux , multiple drug resistance , pharmacology , drug resistance , medicine , cancer research , cancer , imatinib mesylate , biology , microbiology and biotechnology , myeloid leukemia , genetics